These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27699546)

  • 1. Vaccination Expectations in HNSCC.
    Syrjänen S; Rautava J
    Recent Results Cancer Res; 2017; 206():257-267. PubMed ID: 27699546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of B lymphocyte infiltration in HPV
    Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
    Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
    Faraji F; Zaidi M; Fakhry C; Gaykalova DA
    Microbes Infect; 2017; 19(9-10):464-475. PubMed ID: 28619685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
    Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
    Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
    Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
    Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma.
    Donà MG; Giuliani M; Vocaturo A; Spriano G; Pichi B; Rollo F; Ronchetti L; Covello R; Pescarmona E; Benevolo M
    Cancer; 2014 Nov; 120(22):3477-84. PubMed ID: 25043660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
    Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
    Speel EJ
    Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of oral HPV infection among healthy individuals and head and neck cancer cases in the French West Indies.
    Auguste A; Gaëte S; Herrmann-Storck C; Michineau L; Joachim C; Deloumeaux J; Duflo S; Luce D
    Cancer Causes Control; 2017 Nov; 28(11):1333-1340. PubMed ID: 28948421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
    Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
    Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.